基酸通过AMPK/mTOR/ULK1-介导的自激活来改善乙氨基诱导的肝损伤
Yu-Xin Yao1,2,3, Chen-Hao Yao1,2,3, Chao-Yang Zhang1,2,3
1State Key Laboratory of Southwestern Chinese Medicine Resources, Chengdu 611137, China.
The American journal of Chinese medicine
|March 27, 2025
概括
酸 (CGA) 通过激活AMPK/mTOR/ULK1通路,促进自,从而防止乙氨基诱导的肝损伤 (AILI). 这种机制减轻氧化应激和肝损伤,为AILI提供治疗策略.
科学领域:
- 肝病学 肝病学是一种肝病学.
- 细胞生物学 细胞生物学
- 药理学 药理学是指药理学的学科.
背景情况:
- 乙氨基 (APAP) 诱导的肝损伤 (AILI) 是急性肝衰竭的主要原因.
- 自,特别是AMP激活蛋白激酶 (AMPK) /乳动物目标的拉巴胺素 (mTOR) /unc-51-like激酶1 (ULK1) 途径,在APAP肝毒性中起着至关重要的作用.
- 这种途径的药理激活是AILI的一种有前途的治疗策略.
研究的目的:
- 调查酸 (CGA) 对AILI的保护作用.
- 阐明CGA在AILI中调节自的基本机制.
- 在体外和体外模型中探索CGA对AMPK/mTOR/ULK1通路的影响.
主要方法:
- 向小鼠和LO2细胞给予CGA,这些小鼠和LO2细胞遭受了APAP诱导的肝损伤.
- 评估肝损伤标志物和氧化应激水平.
- 分析了与自相关的蛋白质表达 (p62,LC3B,ATG5,Beclin1) 和通路激活 (AMPK/mTOR/ULK1).
- 使用化合物C (CC) 抑制AMPK并评估其对CGA保护机制的影响.
主要成果:
- 在小鼠和LO2细胞中,CGA对APAP诱导的肝损伤和氧化应激产生显著的保护.
- CGA治疗促进了自,由p62降解和LC3B,ATG5和Beclin1.1的升调证明.
- CGA激活了AMPK/mTOR/ULK1的信号通路.
- 化合物C对AMPK的抑制取消了CGA的保护作用,证实了该途径的重要作用.
结论:
- CGA有效地减轻了APAP诱导的肝损伤和氧化应激.
- CGA通过激活AMPK/mTOR/ULK1通路来发挥其保护作用,从而促进自.
- 这些发现强调了CGA作为AILI的潜在治疗剂,取决于其对AMPK/mTOR/ULK1轴的调节作用.
相关概念视频
Phase II Reactions: Glutathione Conjugation and Mercapturic Acid Formation
122
Glutathione, a tripeptide made up of glutamate, cysteine, and glycine, is a critical player in the detoxification of drugs and xenobiotics via a process known as glutathione conjugation or mercapturic acid formation. This phase II biotransformation reaction involves the covalent binding of glutathione to a drug or its metabolite, enhancing the compound's water solubility and enabling its excretion.
Several distinctive characteristics distinguish glutathione conjugation from other phase II...
Several distinctive characteristics distinguish glutathione conjugation from other phase II...
122
Phase II Reactions: Acetylation Reactions
148
Acetylation, a phase II biotransformation reaction, introduces an acetyl group to drugs or their metabolites. Acetyltransferase enzymes facilitate this reaction, which resembles α-amino acid conjugation due to the addition of a functional group to the drug molecule.
The substrates for acetylation are typically drugs or their metabolites with an amino, sulfonamide, or hydrazine functional group. Acetylation can occur at several points in the drug molecule, including primary, secondary, and...
The substrates for acetylation are typically drugs or their metabolites with an amino, sulfonamide, or hydrazine functional group. Acetylation can occur at several points in the drug molecule, including primary, secondary, and...
148


